Veterinary Medicines

Suiseng Coli/C injektionsvæske, suspension

Authorised
  • Clostridium novyi, type B, alpha toxoid
Download as PDF

Product identification

Medicine name:
Suiseng Coli/C injektionsvæske, suspension
Active substance:
  • Clostridium novyi, type B, alpha toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Clostridium perfringens, type C, beta toxoid
    1.05
    relative potency
    /
    1.00
    Dose
  • Clostridium novyi, type B, alpha toxoid
    1.23
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F6
    80.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F5
    79.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ac
    78.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ab
    65.00
    percent
    /
    1.00
    Dose
  • Escherichia coli, LT toxoid
    55.00
    percent
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 69967
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Vet-Med SIA
Destination wholesaler:
  • PharmaMenta ApS